-
Top Stories: Twenty-First Century Fox (NASDAQ:FOXA), Puma Biotechnology (NYSE:PBYI), BP p.l.c. (NYSE:BP), Vermilion Energy Inc. (NYSE:VET), Ericsson (NASDAQ:ERIC)
On Friday shares of Twenty-First Century Fox, Inc. (NASDAQ:FOXA) closed at $33.99. Company’s sales growth for last 5 years was 0.90% and EPS growth for next 5 years is recorded as 16.19%. Twenty-First Century Fox Inc (NASDAQ:FOXA)‘s stock had its “buy” rating reiterated by equities research analysts at Nomura in a research note issued to…
-
Watch List: Puma Biotechnology (NYSE:PBYI), Telefonica Brasil, S.A. (NYSE:VIV), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), FactSet Research Systems Inc. (NYSE:FDS), CLARCOR Inc. (NYSE:CLC)
On Tuesday shares of Puma Biotechnology, Inc. (NYSE:PBYI) closed at $204.00. On May 12, Puma Biotechnology, Inc. (NYSE:PBYI), announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will participate in an analyst-led fireside chat at 9:30 a.m. EDT on Tuesday, May 19, at the UBS Global Healthcare Conference. The conference…
-
Active Stocks to Watch: Puma Biotechnology (NYSE:PBYI), Merck & Co. Inc. (NYSE:MRK), Heritage-Crystal Clean, Inc (NASDAQ:HCCI), Advent Software (NASDAQ:ADVS)
On Monday shares of Puma Biotechnology, Inc. (NYSE:PBYI) closed at $200.98. Puma Biotechnology, Inc. (NYSE:PBYI), announced financial results for the first quarter ended March 31, 2015. Based on accounting principles generally accepted in the United States (GAAP), Puma reported a net loss applicable to common stock of $52.5 million, or $1.66 per share, for the…
-
Why Making Dramatic Moves: Cytori Therapeutics (NASDAQ:CYTX), Puma Biotechnology (NYSE:PBYI), Gulfmark Offshore (NYSE:GLF), Nortel Inversora (NYSE:NTL), LightPath Technologies (NASDAQ:LPTH)
On Thursday shares of Cytori Therapeutics, Inc. (NASDAQ:CYTX) closed at $0.69. Company’s sales growth for last 5 years was -12.40%. On May 05, Cytori Therapeutics (NASDAQ: CYTX) announced the pricing of a registered direct public offering of Units, with each Unit consisting of one share of our common stock and one warrant to purchase one…
-
What’s Hot Today: Ally Financial Inc. (NYSE:ALLY), Puma Biotechnology (NYSE:PBYI), Google Inc (NASDAQ:GOOG), Ford Motor Company (NYSE:F), Targacept (NASDAQ:TRGT)
On Tuesday shares of Ally Financial Inc. (NYSE:ALLY) closed at $21.27. Company’s sales growth for last 5 years was -8.10% and EPS growth for next 5 years is recorded as 16.43%. Ally Financial Inc, the largest U.S. auto lender, reported a quarterly profit that more than doubled, helped by a one-time after-tax gain of about…
-
Investors Are Watching: Oxford Immunotec Global PLC (NASDAQ:OXFD), Puma Biotechnology (NYSE:PBYI), Getty Realty Corp. (NYSE:GTY), Citigroup (NYSE:C), Delta Air Lines (NYSE:DAL)
On Monday shares of Oxford Immunotec Global PLC (NASDAQ:OXFD) closed at $13.27. Company’s sales growth for last 5 years was 63.00% On 24 March, Oxford Immunotec Global PLC (NASDAQ:OXFD) announced its support of the recipient of the 2015 Sir John Crofton Prize for TB Nursing. Puma Biotechnology, Inc. (NYSE:PBYI) in last trading activity increased 11.00%…
-
Big Movers: Advanced Micro Devices (NASDAQ:AMD), Whiting Petroleum Corp. (NYSE:WLL), Puma Biotechnology (NYSE:PBYI), HudBay Minerals (NYSE:HBM), International Business Machines (NYSE:IBM)
On Tuesday shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) closed at $2.79. Company’s sales growth for last 5 years was 0.40%. Advanced Micro Devices, Inc. (NASDAQ:AMD)’s highly anticipated Zen core will feature a plethora of new instruction sets, but will also lose some Bulldozer specific ones in the process and for good reason. This information…
-
Investors Should Watch: Akorn (NASDAQ:AKRX), Puma Biotechnology (NYSE:PBYI), Jiayuan.com International (NASDAQ:DATE), Acacia Research Corporation (NASDAQ:ACTG), Delta Air Lines (NYSE:DAL)
Akorn, Inc. (NASDAQ:AKRX) just recently reaffirmed its 2015 EPS metrics issued on February 26, 2015 calling for revenue of between $960 million and $980 million and adjusted diluted earnings per share (EPS) of between $1.88 and $1.98. Akorn’s Chief Financial Officer Tim Dick will present at the Barclays Global Healthcare Conference on Thursday, March 12,…
-
Stock in News: Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Puma Biotechnology (NYSE:PBYI), MBIA Inc. (NYSE:MBI), Ericsson (NASDAQ:ERIC), Peoples Bancorp Inc. (NASDAQ:PEBO)
On 2 March 2015, Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) reported a loss of 44 cents per share in the fourth quarter of 2014, much wider than both the Zacks Consensus Estimate of a loss of 38 cents and the year-ago quarter figure of 21 cents. On Thursday shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) closed at $13.19.…